Claims for Patent: 9,259,445

Summary for Patent: 9,259,445

Title:	Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
Abstract:	The present invention refers to an Integrated Implant System constituted as a gel-matrix-cells integrated system, that allows providing implants in a brief time period, for covering a great skin extension to be treated, with a successful acceptance in patients with burns, chronic damage or wound skin, needing of a skin grafting.
Inventor(s):	Young Anze; Manuel Eduardo (Valparaiso, CL), Acevedo Gutierrez; Cristian Andres (Valparaiso, CL), Albornoz Marquez; Fernando Antonio (Valparaiso, CL), Weinstein Oppenheimer; Caroline Ruth (Valparaiso, CL), Aceituno Alvarez; Alexis Roobins (Valparaiso, CL), Brown Gonzalez; Donald Irving (Valparaiso, CL), Tapia Murua; Sergio Miguel (Valparaiso, CL)
Assignee:	UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (Valparaiso, V Region, CL) UNIVERSIDAD DE VALPARAISO (Valparaiso, V Region, CL) FUNDACION INSTITUTO DE SEGURIDAD DEL TRABAJO (Valparaiso, V Region, CL)
Application Number:	12/303,714
Patent Claims:	1. A method for preparing an implant system that comprises a sterile, porous, biocompatible polymeric matrix and a gel intimately associated in the interior of the matrix, wherein the method is carried out in a sterile environment and comprises the steps of: a) providing a tridimensional polymeric matrix structure that comprises crosslinked gelatine, chitosan and hyaluronic acid; b) next, applying to said tridimensional polymeric matrix structure a volume of a solution comprising thrombin and cells; c) allowing the solution to be absorbed in the tridimensional polymeric matrix structure, during an appropriate time of period; d) then adding a fibrinogen solution to form a gel that is integrated in situ to the tridimensional polymeric matrix structure; and e) incubating the gel-integrated tridimensional polymeric matrix structure under conditions appropriate for forming an implant system. 2. The method for preparing an implant system, according to claim 1, wherein prior to step b) the tridimensional polymeric matrix structure of step a) is immersed in an alcoholic solution, during one hour; removed from the alcoholic solution and dried; and subsequently submerged in Dulbecco's Modified Eagle's Medium and Ham's F-12 Nutrient Mixture (DMEM/F12) medium during a time period of about 18 hours to about 30 hours. 3. The method for preparing the implant system, according to the claim 1, wherein the sterile environment is achieved through irradiation or ultraviolet (UV) light. 4. The method for preparing an implant system, according to claim 2, wherein the method further comprises submerging the formed implant system in DMEM/F-12, DMEM, Roswell Park Memorial Institute (RPMI) or Minimum Essential Media (MEM) medium. 5. The method for preparing an implant system, according to claim 2, wherein the alcoholic solution consists of a solution comprising sterile water and an alcohol selected from the group consisting of ethanol, propanol or isopropanol, and mixtures thereof. 6. The method according to claim 1 wherein the method is carried out ex vivo in a sterile environment, wherein the solution consists of thrombin and cells, the step of allowing the solution to be absorbed during the appropriate time of period to absorb the cells and the thrombin throughout the matrix structure, and the gel formed with the thrombin is integrated with the cells within the interior of the tridimensional polymeric matrix structure. 7. The method according to claim 1 wherein the cells and thrombin of step c) are absorbed through the full depth or thickness of the matrix.

Details for Patent 9,259,445

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2026-06-07